Toggle Main Menu Toggle Search

Open Access padlockePrints

Impact of the UKPDS - An overview

Lookup NU author(s): Emeritus Professor Philip Home


Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


The UK Prospective Diabetes Study (UKPDS) is a group of clinical trials, epidemiological analyses and health-modelling studies with an influence which can be assessed across a broad range of health domains. Original publications (n = 85) are notable for being mainly published in the key weekly or diabetes journals (78%) and being mainly in the clinical arena (68%). Notable reference to the publications can be found in UK National Institute for Clinical Excellence (NICE) guidelines, but also in evidence-based international guidelines, where UKPDS papers form a significant fraction of the citations. In educational materials UKPDS-derived slides remain popular (10 and 30% of some international slide sets), again as much for the epidemiological findings as for the core trial results. Slides of the deterioration in blood glucose control with time, and evidence that this is as a result of progressive decline of pancreatic islet B-cell function, are used particularly often. The UKPDS enhanced the promotion of glycated haemoglobin to its core role in clinical monitoring, through understanding of the quantitative relationship of vascular complications to glucose control, and thus to target setting. Notably, metformin therapy was promoted by the UKPDS findings on macrovascular disease in the overweight study, although controversy remains regarding the significance of the effect on macrovascular disease of the core glucose-lowering study, promoting the development of further studies reporting in 2008. The effects of decreasing blood pressure on microvascular disease have had an important impact on guidelines and health economic analyses, together with other evidence on the value of rennin-angiotensin system blockers. The UKPDS has evidently been unusually influential in the development of treatment guidelines, clinical education and the thinking of healthcare professionals. By inference it must be responsible for a significant part of the improvement in health outcomes in people with Type 2 diabetes over the last decade. © 2008 The Author.

Publication metadata

Author(s): Home PD

Publication type: Review

Publication status: Published

Journal: Diabetic Medicine

Year: 2008

Volume: 25

Issue: s2

Pages: 2-8

ISSN (print): 0742-3071

ISSN (electronic): 1464-5491


DOI: 10.1111/j.1464-5491.2008.02501.x

Notes: Special Issue: The UK Prospective Diabetes Study: celebrating 30 years